Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19

IM Dumitru, M Dumitrascu, ND Vlad, RC Cernat… - Antibiotics, 2021 - mdpi.com
Infections with carbapenem-resistant Enterobacteriaceae are emerging as an important
challenge in healthcare settings. Currently, carbapenem-resistant Klebsiella pneumoniae …

[HTML][HTML] Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball

G Montrucchio, S Corcione, G Sales, A Curtoni… - Journal of global …, 2020 - Elsevier
Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019
(COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive …

Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients—A Scoping Review

W Mędrzycka-Dąbrowska, S Lange, K Zorena… - Journal of Clinical …, 2021 - mdpi.com
Introduction: The spread of multidrug-resistant pathogens is a serious problem and
challenge for the whole medical community. Carbapenem-resistant Klebsiella pneumoniae …

Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 patients …

B Tiri, E Sensi, V Marsiliani, M Cantarini… - Journal of clinical …, 2020 - mdpi.com
The Italian burden of disease associated with infections due to antibiotic-resistant bacteria
has been very high, largely attributed to Carbapenem-Resistant Klebsiella pneumoniae (CR …

Prevalence and impact on mortality of colonization and super-infection by carbapenem-resistant gram-negative organisms in COVID-19 hospitalized patients

R Casale, G Bianco, P Bastos, S Comini, S Corcione… - Viruses, 2023 - mdpi.com
Background: The relationship between superinfection by multidrug-resistant Gram-negative
bacteria and mortality among SARS-CoV-2 hospitalized patients is still unclear …

Carbapenem-Resistant Klebsiella pneumoniae in COVID-19 Era—Challenges and Solutions

J Ficik, M Andrezál, H Drahovská, M Böhmer… - Antibiotics, 2023 - mdpi.com
The COVID-19 era brought about new medical challenges, which, together with nosocomial
bacterial infections, resulted in an enormous burden for the healthcare system. One of the …

[HTML][HTML] Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital

G Arcari, G Raponi, F Sacco, G Bibbolino… - International journal …, 2021 - ncbi.nlm.nih.gov
Italy has experienced one of the harshest and earliest COVID-19 (coronavirus disease
2019) epidemics, with the number of patients infected following, from the end of February up …

Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case–control study

ND Vlad, RC Cernat, S Carp, R Mitan… - Journal of …, 2022 - journals.sagepub.com
Objective To identify carbapenem-resistant Enterobacteriaceae (CRE) in patients infected
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) and to …

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional …

R Pascale, L Bussini, P Gaibani, F Bovo… - Infection Control & …, 2022 - cambridge.org
Objective: To assess the incidence of colonization and infection with carbapenemase-
producing Enterobacteriaceae (CPE) and carbapenem-resistant Acinetobacter baumannii …

[HTML][HTML] Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care …

G Bianco, M Boattini, A Bondi, S Comini… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales (KPC-EB)
represent a major threat because of their wide spread in healthcare facilities, difficult-to-treat …